KINGDON CAPITAL MANAGEMENT, L.L.C. - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 187 filers reported holding CARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
KINGDON CAPITAL MANAGEMENT, L.L.C. ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$6,054,030
-57.7%
1,233,000
-7.5%
1.14%
-60.1%
Q4 2022$14,316,420
+14.7%
1,333,0000.0%2.85%
+78.6%
Q3 2022$12,477,000
+2.5%
1,333,0000.0%1.60%
-22.7%
Q2 2022$12,171,000
-15.3%
1,333,000
+12.7%
2.06%
+37.8%
Q1 2022$14,373,000
+33.6%
1,183,000
+34.0%
1.50%
+21.1%
Q4 2021$10,755,000
-2.7%
883,000
+23.4%
1.24%
-8.0%
Q3 2021$11,057,000
+79.3%
715,684
+65.6%
1.34%
+88.1%
Q2 2021$6,167,000
-60.9%
432,178
-40.5%
0.72%
-55.6%
Q1 2021$15,774,000
+66.4%
726,583
+16.0%
1.61%
+57.2%
Q4 2020$9,480,000
+18.9%
626,5830.0%1.02%
+14.5%
Q3 2020$7,973,000
-25.6%
626,5830.0%0.90%
-8.2%
Q2 2020$10,715,000
+29.5%
626,5830.0%0.98%
-35.6%
Q1 2020$8,277,000
+9.0%
626,583
+32.9%
1.52%
+32.4%
Q4 2019$7,597,000
+47.5%
471,575
+67.3%
1.14%
+88.2%
Q3 2019$5,151,000
+19.5%
281,808
+40.6%
0.61%
+43.4%
Q2 2019$4,311,000
+1597.2%
200,500
+1115.2%
0.42%
+2394.1%
Q2 2017$254,00016,5000.02%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,204,449$10,8241.35%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,233,000$6,054,0301.14%
Chescapmanager LLC 1,160,392$5,6980.90%
DISCIPLINED GROWTH INVESTORS INC /MN 1,732,375$8,505,9610.22%
XTX Topco Ltd 107,610$528,3650.11%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 84,530$415,0420.08%
PINNACLE ASSOCIATES LTD 679,413$3,335,9180.07%
PDT Partners, LLC 102,010$500,8690.07%
FARALLON CAPITAL MANAGEMENT LLC 1,995,370$9,797,2670.05%
AXQ CAPITAL, LP 27,760$136,3020.05%
View complete list of CARA THERAPEUTICS INC shareholders